[Nephrotic syndrome and skin disorders appearing during alpha-mercapto-propionyl-glycine treatment of 2 cases of cystinic lithiasis].
D000328:Adult; D000603:Amino Acids, Sulfur / Q000009:adverse effects*; D003553:Cystine / Q000378:metabolism*; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D009404:Nephrotic Syndrome / Q000139:chemically induced*; D011537:Pruritus / Q000139:chemically induced; D008625:Tiopronin / Q000009:adverse effects* / Q000627:therapeutic use; D014581:Urticaria / Q000139:chemically induced*
D000603:Amino Acids, Sulfur; D003553:Cystine; D008625:Tiopronin
Syndrome néphrotique et troubles cutanés survenus au cours du traitement de deux cas de lithiase cystinique par l'alpha-mercapto-propionyl-glycine.